Leadiant Biosci Inc Drug Patent Portfolio
Leadiant Biosci Inc owns 2 orange book drugs protected by 5 US patents Given below is the list of Leadiant Biosci Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6335369 | Treating chronic uremic patients undergoing periodical dialysis | 18 Jan, 2021 | Expired |
| US6429230 | Treating chronic uremic patients undergoing periodical dialysis | 18 Jan, 2021 | Expired |
| US6696493 | Treating chronic uremic patients undergoing periodic dialysis | 18 Jan, 2021 | Expired |
| US6406713 | Methods of preparing low-toxicity drug-lipid complexes | 18 Jun, 2019 | Expired |
| US5616334 | Low toxicity drug-lipid systems | 01 Apr, 2014 | Expired |
Latest Legal Activities on Leadiant Biosci Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Leadiant Biosci Inc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| File Marked Found | 19 Jan, 2016 | US6335369 |
| File Marked Found | 19 Jan, 2016 | US6429230 |
| File Marked Found | 19 Jan, 2016 | US6696493 |
| File Marked Found | 14 Jan, 2016 | US6335369 |
| File Marked Found | 14 Jan, 2016 | US6696493 |
| File Marked Found | 14 Jan, 2016 | US6429230 |
|
Correspondence Address Change
Critical
| 05 Jun, 2006 | US6429230 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 24 Feb, 2004 | US6696493 |
|
Recordation of Patent Grant Mailed
Critical
| 24 Feb, 2004 | US6696493 |
|
Issue Notification Mailed
Critical
| 05 Feb, 2004 | US6696493 |
| Receipt into Pubs | 22 Jan, 2004 | US6696493 |
| Receipt into Pubs | 21 Jan, 2004 | US6696493 |
| Receipt into Pubs | 29 Dec, 2003 | US6696493 |
|
Application Is Considered Ready for Issue
Critical
| 22 Dec, 2003 | US6696493 |
| Receipt into Pubs | 16 Dec, 2003 | US6696493 |
Leadiant Biosci Inc's Drug Patent Litigations
Leadiant Biosci Inc's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Mar 30, 2001, against patent number US6406713. The petitioner , challenged the validity of this patent, with JANOFF et al as the respondent. Click below to track the latest information on how companies are challenging Leadiant Biosci Inc's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US6406713 | March, 2001 |
Decision
(19 Dec, 2001)
| JANOFF et al | |
Leadiant Biosci Inc's Family Patents
Leadiant Biosci Inc Drug List
Given below is the complete list of Leadiant Biosci Inc's drugs and the patents protecting them.
1. Abelcet
Abelcet is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6406713 | Methods of preparing low-toxicity drug-lipid complexes |
18 Jun, 2019
(5 years ago)
| Expired |
| US5616334 | Low toxicity drug-lipid systems |
01 Apr, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Abelcet's drug page
2. Carnitor
Carnitor is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6335369 | Treating chronic uremic patients undergoing periodical dialysis |
18 Jan, 2021
(3 years ago)
| Expired |
| US6429230 | Treating chronic uremic patients undergoing periodical dialysis |
18 Jan, 2021
(3 years ago)
| Expired |
| US6696493 | Treating chronic uremic patients undergoing periodic dialysis |
18 Jan, 2021
(3 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Carnitor's drug page